Literature DB >> 25920730

Factors affecting the progression of renal dysfunction and the importance of salt restriction in patients with type 2 diabetic kidney disease.

Noriko Kanauchi1, Susumu Ookawara2, Kiyonori Ito3, Satsuki Mogi1, Izumi Yoshida3, Masafumi Kakei4, San-E Ishikawa4, Yoshiyuki Morishita3, Kaoru Tabei3.   

Abstract

BACKGROUND: Type 2 diabetic kidney disease (DKD) is the most common cause of end-stage renal failure, and the prevention of its progression has been a topic of discussion.
METHODS: Sixty type 2 DKD patients were retrospectively evaluated for 1 year. Factors independently affecting the annual Ccr decline were examined by multivariable linear regression analysis. Patients were further divided into 2 groups based on their degree of renal function, and between-group differences at study initiation were evaluated.
RESULTS: Ccr values were 21.0 ± 11.8 mL/min/1.73 m(2) at study initiation, and 15.7 ± 10.9 mL/min/1.73 m(2) after 1 year of observation. The multivariable linear regression analysis indicated salt intake (standardized coefficient: -0.34, P = 0.010) and urinary protein excretion (standardized coefficient: -0.33, P = 0.011) to be factors independently affecting the annual Ccr decline. Although decliners (-9.8 ± 4.7 mL/min/1.73 m(2)/year) had a significantly higher salt intake than non-decliners (-1.1 ± 3.8 mL/min/1.73 m(2)/year) at study initiation, this difference disappeared at the end of the study as a result of intensive dietary education. In 21 decliners with an additional year of follow-up, the annual Ccr decline significantly improved from -10.1 ± 5.3 to -5.3 ± 7.4 mL/min/1.73 m(2)/year (P = 0.02).
CONCLUSION: Salt intake and urinary protein excretion were associated with annual Ccr decline in type 2 DKD patients. Furthermore, dietary education covering salt intake may have positively affected the change in Ccr.

Entities:  

Keywords:  Annual Ccr decline; Salt intake; Salt restriction; Type 2 diabetic kidney disease; Urinary protein excretion

Mesh:

Substances:

Year:  2015        PMID: 25920730     DOI: 10.1007/s10157-015-1118-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  24 in total

1.  Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?

Authors:  G Remuzzi; T Bertani
Journal:  Kidney Int       Date:  1990-09       Impact factor: 10.612

2.  Standards of medical care in diabetes--2011.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

3.  Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.

Authors:  Giacomo Zoppini; Giovanni Targher; Michel Chonchol; Vittorio Ortalda; Carlo Negri; Vincenzo Stoico; Enzo Bonora
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

4.  Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches.

Authors:  Thomas C Dowling; Gary R Matzke; John E Murphy; Gilbert J Burckart
Journal:  Pharmacotherapy       Date:  2010-08       Impact factor: 4.705

Review 5.  Ca2+ channel subtypes and pharmacology in the kidney.

Authors:  Koichi Hayashi; Shu Wakino; Naoki Sugano; Yuri Ozawa; Koichiro Homma; Takao Saruta
Journal:  Circ Res       Date:  2007-02-16       Impact factor: 17.367

6.  UK Renal Registry 12th Annual Report (December 2009): chapter 4: UK ESRD prevalent rates in 2008: national and centre-specific analyses.

Authors:  Catherine Byrne; Retha Steenkamp; Clare Castledine; David Ansell; John Feehally
Journal:  Nephron Clin Pract       Date:  2010-03-31

7.  The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.

Authors:  William F Keane; Barry M Brenner; Dick de Zeeuw; Jean-Pierre Grunfeld; Janet McGill; William E Mitch; Artur B Ribeiro; Shahnaz Shahinfar; Roger L Simpson; Steven M Snapinn; Robert Toto
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

Review 8.  Angiotensin II blockade and renal protection.

Authors:  Hiroyuki Kobori; Hirohito Mori; Tsutomu Masaki; Akira Nishiyama
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

10.  An overview of regular dialysis treatment in Japan (as of 31 December 2010).

Authors:  Shigeru Nakai; Kunitoshi Iseki; Noritomo Itami; Satoshi Ogata; Junichiro James Kazama; Naoki Kimata; Takashi Shigematsu; Toshio Shinoda; Tetsuo Shoji; Kazuyuki Suzuki; Masatomo Taniguchi; Kenji Tsuchida; Hidetomo Nakamoto; Hiroshi Nishi; Seiji Hashimoto; Takeshi Hasegawa; Norio Hanafusa; Takayuki Hamano; Naohiko Fujii; Ikuto Masakane; Seiji Marubayashi; Osamu Morita; Kunihiro Yamagata; Kenji Wakai; Atsushi Wada; Yuzo Watanabe; Yoshiharu Tsubakihara
Journal:  Ther Apher Dial       Date:  2012-12       Impact factor: 1.762

View more
  2 in total

Review 1.  Diabetic nephropathy: Time to withhold development and progression - A review.

Authors:  Usama A A Sharaf El Din; Mona M Salem; Dina O Abdulazim
Journal:  J Adv Res       Date:  2017-04-21       Impact factor: 10.479

Review 2.  Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management.

Authors:  Mahaboob Khan Sulaiman
Journal:  Diabetol Metab Syndr       Date:  2019-01-23       Impact factor: 3.320

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.